TGFB1 Antikörper (AA 378-382)
Kurzübersicht für TGFB1 Antikörper (AA 378-382) (ABIN7138220)
Target
Alle TGFB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 378-382
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Affinity purification
-
Immunogen
- Peptide sequence around aa.378-382(Q-L-S-N-M) derived from Human TGF-b.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:1000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified Rabbit polyclonal in PBS( pH 7.4) containing with 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- TGFB1
-
Hintergrund
-
Background:
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts.
Aliases: CED, LAP, DPD1, TGFB , TGFbeta
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-